KRYS Krystal Biotech, Inc. | US5011471027
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 670.249.520 | 516.046.110 | 29.88% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 9,87 | 8,21 | 20.30% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 9 | 9 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |